# Axxia Pharmaceuticals, LLC: Form D filings

Axxia Pharmaceuticals, LLC, a pharmaceuticals company in Bel Air, MD, filed 6 Form D notices with the SEC between 2011 and 2017. The latest, on February 2, 2017, reports an offering of $3 million with nothing sold yet.

Find out what Axxia Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Axxia%20Pharmaceuticals%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Axxia%20Pharmaceuticals%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Faxxia-pharmaceuticals-llc-1514545)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Axxia%20Pharmaceuticals%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Axxia%20Pharmaceuticals%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Faxxia-pharmaceuticals-llc-1514545)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2614 WEST MEDICAL HALL ROAD, Bel Air, MD, 21015
- Phone: (610) 255-4474
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Maryland
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1514545

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 2, 2017 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514545/000151454517000003/0001514545-17-000003-index.htm) |
| Feb 14, 2013 | New notice | $300,000 | $0 | $300,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514545/000151454513000001/0001514545-13-000001-index.htm) |
| Mar 12, 2012 | New notice | $800,000 | $300,000 | $500,000 | 1 | Mar 1, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514545/000151454512000001/0001514545-12-000001-index.htm) |
| Sep 23, 2011 | New notice | $350,000 | $0 | $350,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514545/000151454511000003/0001514545-11-000003-index.htm) |
| Apr 1, 2011 | New notice | $100,000 | $100,000 | $0 | 8 | Mar 30, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514545/000151454511000002/0001514545-11-000002-index.htm) |
| Mar 4, 2011 | New notice | $150,000 | $150,000 | $0 | 9 | Feb 18, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1514545/000151454511000001/0001514545-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Wally Phillip Grimm | Director |  |
| Bernard Phillip Rudnick | Executive Officer, Director |  |
| Sally Phillip MacConnell | Director |  |
| D. Phillip Cox | Executive Officer, Director |  |
| Stuart Phillip Grossman | Director |  |
| Wayne Pollock | Executive Officer, Director |  |
| David Phillip Wheatley | Director |  |

[Every Form D from the week of Jan 30, 2017](https://specstream.ai/data/form-d/week/2017-01-30) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Axxia Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).